4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-032747
Chief Development Officer sold 20,000 shares at $59.07 ($1,181,400)
- Chief Development Officer acquired 20,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Guyer William Chief Development Officer | 2025-03-04 | Option exercise 10b5-1 | +20,000 | $19.26 | $385,200 | 25,487 | D: show line 1 in the form |
| Guyer William Chief Development Officer | 2025-03-04 | Sale 10b5-1 | −20,000 | $59.07 | $1,181,400 | 5,487 | D: show line 2 in the form |
| Open-market sales · 20,000 sh · avg $59.07 · $1,181,400 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Guyer William Chief Development Officer | 2025-02-28 | Grant or award · Stock option (right to buy) 10b5-1 | +140,000 | 140,000 | D: show line 3 in the form | ||
| Guyer William Chief Development Officer | 2025-03-04 | Option exercise · Stock option (right to buy) 10b5-1 | −20,000 | 30,000 | D: show line 4 in the form |
Loading xslF345X05/ownership.xml…